Literature DB >> 19580857

Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.

Guiqin Zhao1, Zhifeng Yin, Junxing Dong.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Jasminum officinale L. var. grandiflorum (JOG) is a folk medicine used for the treatment of hepatitis in south of China. Phytochemical studies showed that secoiridoid glycosides are the typical constituents of this plant. AIM OF THE STUDY: The present study was undertaken to evaluate the effect of oleuropein (Ole) derived from the flowers of JOG on hepatitis B virus (HBV) replication in HepG2 2.2.15 cell line in vitro and duck hepatitis B virus (DHBV) replication in ducklings in vivo.
MATERIAL AND METHODS: The extracellular hepatitis B e antigen (HBeAg) and hepatitis B surface antigen (HBsAg) concentrations in cell culture medium were determined by ELISA. DHBV in duck serum was analyzed by dot blot.
RESULTS: Ole blocks effectively HBsAg secretion in HepG2 2.2.15 cells in a dose-dependent manner (IC(50)=23.2 microg/ml). Ole (80 mg/kg, intraperitoneally, twice daily) also reduced viremia in DHBV-infected ducks.
CONCLUSION: Ole therefore warrants further investigation as a potential therapeutic agent for HBV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19580857     DOI: 10.1016/j.jep.2009.06.030

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  14 in total

Review 1.  Phytopharmacological Profile of Jasminum grandiflorum Linn. (Oleaceae).

Authors:  Mittal Arun; Sardana Satish; Pandey Anima
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

2.  Effect of Hepatocyte Targeting Nanopreparation Syringopicroside on Duck Hepatitis B Virus and Evaluation of Its Safety.

Authors:  X W Zhang; M C Li; J J Dou
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.804

3.  Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease.

Authors:  Sinan Bilginer; Sefa Gözcü; Zuhal Güvenalp
Journal:  Turk J Pharm Sci       Date:  2022-08-31

Review 4.  Anti-hepatitis B activities of Myanmar medicinal plants: a narrative review of current evidence.

Authors:  Ye Htut Linn; Win Win Ei; Lwin Mon Mon Myint; Khin Maung Lwin
Journal:  Virusdisease       Date:  2021-07-14

5.  The anti-infarct, antistunning and antiarrhythmic effects of oleuropein in isolated rat heart.

Authors:  Mansour Esmailidehaj; Bahram Rasulian; Mohammad Ebrahim Rezvani; Bahram Delfan; Mohammad Hossein Mosaddeghmehrjardi; Khalil Pourkhalili
Journal:  EXCLI J       Date:  2012-04-03       Impact factor: 4.068

Review 6.  Effects of the olive-derived polyphenol oleuropein on human health.

Authors:  Barbara Barbaro; Gabriele Toietta; Roberta Maggio; Mario Arciello; Mirko Tarocchi; Andrea Galli; Clara Balsano
Journal:  Int J Mol Sci       Date:  2014-10-14       Impact factor: 5.923

7.  The Effect of Convolvulus arvensis Dried Extract as a Potential Antioxidant in Food Models.

Authors:  Nurul Aini Mohd Azman; Maria Gabriela Gallego; Luis Juliá; Lluis Fajari; MaríaPilar Almajano
Journal:  Antioxidants (Basel)       Date:  2015-03-10

8.  ANTIVIRAL ACTIVITY OF DIANTHUS SUPERBUSN L. AGAINST HEPATITIS B VIRUS IN VITRO AND IN VIVO.

Authors:  Wei-Guo Li; He-Qun Wang
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-08-12

9.  Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro.

Authors:  Jaesung Jung; Nam Keun Kim; Sun Park; Ho-Joon Shin; Seong Gyu Hwang; Kyongmin Kim
Journal:  BMC Complement Altern Med       Date:  2015-07-29       Impact factor: 3.659

Review 10.  Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases.

Authors:  Stefania Bulotta; Marilena Celano; Saverio Massimo Lepore; Tiziana Montalcini; Arturo Pujia; Diego Russo
Journal:  J Transl Med       Date:  2014-08-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.